| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
Moiz Rehmanjee
DFI | Director of Finance/CFO | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 30/09/2016 | |
| Chairman | - | 26/10/2017 | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 24.88M | ||
| +0.03% | -3.09% | +52.20% | +91.69% | 1,002B | ||
| -0.76% | -1.52% | +49.94% | +66.34% | 649B | ||
| +0.86% | -3.49% | +19.60% | +68.37% | 440B | ||
| -0.80% | +0.06% | +28.73% | +35.45% | 346B | ||
| -0.13% | -14.74% | +9.13% | +26.71% | 263B | ||
| -1.90% | -2.61% | -2.67% | +7.41% | 250B | ||
| -0.48% | -10.69% | +39.64% | +50.82% | 213B | ||
| -1.06% | -1.70% | -16.73% | -57.36% | 201B | ||
| -0.68% | -2.85% | +25.69% | +91.64% | 182B | ||
| Average | -0.34% | -2.06% | +22.84% | +42.34% | 393.74B | |
| Weighted average by Cap. | -0.10% | -2.39% | +32.37% | +57.01% |
Employees
-
Sector
Pharmaceuticals
















